Additionally, other studies have noted an increased prevalence of NTM in breast cancer tissue compared to normal breast tissue, with further elevation observed in HER2+ breast cancer tissue compared to HER2- counterparts [139,151]. This evidence concerns the gene ERBB2 and breast cancer.